UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061615
Receipt number R000070492
Scientific Title The Effect of Individual Variations in Current Direction Within the Primary Somatosensory Cortex on Tactile Function Induced by tDCS
Date of disclosure of the study information 2026/05/18
Last modified on 2026/05/18 14:21:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effect of Individual Variations in Current Direction Within the Primary Somatosensory Cortex on Tactile Function Induced by tDCS

Acronym

A Study on Individual Differences in the Effects of Weak Electrical Stimulation of the Brain on Tactile Function

Scientific Title

The Effect of Individual Variations in Current Direction Within the Primary Somatosensory Cortex on Tactile Function Induced by tDCS

Scientific Title:Acronym

The Effect of tDCS Current Direction on Tactile Function

Region

Japan


Condition

Condition

Central nervous system disorders

Classification by specialty

Neurology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will use individual MRI scans and electric field simulations to evaluate the direction of the electric field vectors generated within each subject's S1 when tDCS is applied to S1 using a fixed electrode configuration. Furthermore, by clarifying the relationship between the direction of the current applied to S1 and changes in tactile function and somatosensory evoked potentials (SEP), we aim to elucidate the neurophysiological factors underlying individual differences in the effects of tDCS stimulation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Grating orientation task(Measured before and after the tDCS intervention)

Key secondary outcomes

Somatosensory Evoked Potential


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Transcranial Direct Current Stimulation
Stimulation duration: 20 minutes; stimulation intensity: 2 mA; fade-in/fade-out: 15 seconds each; electrode size: 5 x 5 cm
Conventional electrode placement conditions

Interventions/Control_2

Transcranial Direct Current Stimulation
Stimulation duration: 20 minutes; stimulation intensity: 2 mA; fade-in/fade-out: 15 seconds each; electrode size: 5 x 5 cm
Current applied perpendicular to the gyri

Interventions/Control_3

Transcranial Direct Current Stimulation
Stimulation duration: 20 minutes; stimulation intensity: 2 mA; fade-in/fade-out: 15 seconds each; electrode size: 5 x 5 cm
Condition: Current parallel to the gyri

Interventions/Control_4

Transcranial Direct Current Stimulation
Stimulation duration: first 30 seconds; stimulation intensity: 2 mA; fade-in and fade-out: 15 seconds each; electrode size: 5 x 5 cm
Sham condition

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

The inclusion criteria were right-handed, healthy adults aged 18 to 30 who were eligible for MRI and tDCS, had received a thorough explanation of the study, and had provided written informed consent.

Key exclusion criteria

Exclusion criteria included individuals with a history of neurological or psychiatric disorders, those with sensory impairments or upper limb dysfunction, those with contraindications for MRI or tDCS, those taking medications that affect neural excitability, and those deemed unable to complete the study.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Yusuke
Middle name
Last name Sekine

Organization

Niigata University of Health and Welfare

Division name

Graduate School of Health and Welfare Sciences, Doctoral Program

Zip code

950-3198

Address

1398 Shimami-cho, Kita Ward, Niigata City, Niigata Prefecture

TEL

025-257-4455

Email

hwd26011@nuhw.ac.jp


Public contact

Name of contact person

1st name Yusuke
Middle name
Last name Sekine

Organization

Niigata University of Health and Welfare

Division name

Graduate School of Health and Welfare Sciences, Doctoral Program

Zip code

950-3198

Address

1398 Shimami-cho, Kita Ward, Niigata City, Niigata Prefecture

TEL

025-257-4455

Homepage URL


Email

hwd26011@nuhw.ac.jp


Sponsor or person

Institute

Niigata University of Health and Welfare

Institute

Department

Personal name

Sekine Yusuke


Funding Source

Organization

Niigata University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee, Niigata University of Health and Welfare

Address

1398 Shimami-cho, Kita Ward, Niigata City, Niigata Prefecture

Tel

0252574455

Email

rinri@nuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 05 Month 18 Day

Date of IRB


Anticipated trial start date

2026 Year 05 Month 18 Day

Last follow-up date

2029 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 18 Day

Last modified on

2026 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070492